Schizophrenia as a Comorbidity in COVID-19 Infection in Indonesia

Lia Jessica, Yunias Setiawati, Ari Baskoro, Satria Arief Wibowo, Andronikus Dharmawan


Schizophrenia is a mental disorder affecting almost 1% of the global population. COVID-19 makes schizophrenia patients more vulnerable to poor outcomes because of their immune system disorder. When a patient is diagnosed with COVID-19, they must isolate for at least 14 days. This is where consultation liaison psychiatrists have a great role to play, both in delivering the news and in helping the patients to cope during their illness. The way in which health workers communicate with the patients should also be adjusted during the pandemic to limit the spread of COVID-19. This is a case report of a male paranoid schizophrenia patient who was also diagnosed with COVID-19 during his hospitalization. We used consultation liaison psychiatry techniques to break the news of his COVID-19 diagnosis. The patient refused to be isolated at first, but finally agreed after we had explained the situation further to him. Telepsychiatry could be an alternative way to communicate with an isolated COVID-19 patient as long as both the doctor and the patient were comfortable with the method. We used it to communicate with the patient until his discharge from hospital and he seemed quite comfortable with it. This article aims to raise awareness of the possibility of COVID-19 infection in a schizophrenic patient and highlight the role of consultation liaison psychiatrists in delivering the bad news about COVID-19 infection. The use of telepsychiatry for a psychiatric patient who needs to be isolated due to COVID-19 could also be a safer and more comfortable way to communicate, for both the doctor and the patient.


Keywords: Consultation-Liaison Psychiatry, COVID-19, mental disorder, schizophrenia, telepsychiatry.



Full Text:



WU Y. C., CHEN C. S., and CHAN Y. J. The outbreak of COVID-19: An overview. Journal of the Chinese Medical Association, 2020, 83(3): 217-220.

ZHOU R., LI F., CHEN F., LIU H., and ZHENG J. Viral dynamics in asymptomatic patients with COVID-19. International Journal of Infectious Diseases, 2020, 96: 288-290.

NURAINI R. Kasus Covid-19 Pertama, Masyarakat Jangan Panik, 2020.

PETA SEBARAN COVID-19. Infografis COVID-19, 2020.

STĘPNICKI P., KONDEJ M., and KACZOR A. A. Current concepts and treatments of schizophrenia. Molecules, 2018, 23(8): 2087.

GAEBEL W., & ZIELASEK J. Schizophrenia in 2020: Trends in diagnosis and therapy. Psychiatry and Clinical Neurosciences, 2015, 69(11): 661-673.

GADELHA A., FONSECA L., DINIZ E., MENDONCA G., MALINOWSKI F., and MARI J. Schizophrenia and COVID-19: Risks and recommendations. Brazilian Journal of Psychiatry, 2020, 42(3): 236-238.

KOZLOFF N., MULSANT B. H., STERGIOPOULOS V., and VOINESKOS A. N. The COVID-19 global pandemic: Implications for people with schizophrenia and related disorders. Schizophrenia Bulletin, 2020, 46(4): 752-757.

SETIAWATI Y., WAHYUHADI J., JOESTANDARI F., MARAMIS M. M., and ATIKA A. Anxiety and Resilience of Healthcare Workers During COVID-19 Pandemic in Indonesia. Journal of Multidisciplinary Healthcare, 2021, 14: 1-8.

GROVER S., & AVASTHI A. Consultation-Liaison Psychiatry in India: Where to go from here? Indian Journal of Psychiatry, 2019, 61(2): 117-124.

GÜNER R., HASANOĞLU İ., and AKTAŞ F. COVID-19: Prevention and control measures in community. Turkish Journal of Medical Sciences, 2020, 50: 571-577.

LOEFFELHOLZ M. J., & TANG Y. W. Laboratory diagnosis of emerging human coronavirus infections–the state of the art. Emerging Microbes and Infections, 2020, 9(1): 747-756.

GAO Z., XU Y., SUN C., WANG X., GUO Y., QIU S., and MA K. A systematic review of asymptomatic infections with COVID-19. Journal of Microbiology, Immunology and Infection, 2021, 54(1): 12-16.

JIN X., LIAN J. S., HU J. H., GAO J., ZHENG L., ZHANG Y. M., HAO S. R., JIA H. Y., CAI H., ZHANG X. L., YU G. D., XU K. J., WANG X. Y., GU J. Q., ZHANG S. Y., YE C. Y., JIN C. L., LU Y. F., YU X., YU X. P., HUANG J. R., XU K. L., NI Q., YU C. B., ZHU B., LI Y. T., LIU J., ZHAO H., ZHANG X., YU L., GUO Y. Z., SU J. W., TAO J. J., LANG G. J., WU X. X., WU W. R., QV T. T., XIANG D. R., YI P., SHI D., CHEN Y., REN Y., QIU Y. Q., LI L. J., SHENG J., and YANG Y. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut, 2020, 69(6): 1002-1009.

HE H., ZHAO S., and HAN L. The relative transmissibility of asymptomatic COVID-19 infections among close contacts. International Journal of Infectious Diseases, 2020, 94: 145-147.

BASKORO A. Problematika Vaksinasi Pada Disabilitas Mental. PAPDI Surabaya, 2021, 83: 1-4.

SÁNCHEZ-GONZÁLEZ M. Á. The Role of Consultation-Liaison Psychiatry in the COVID-19 Pandemic. The Primary Care Companion for CNS Disorders, 2020, 22: 20com02669.


  • There are currently no refbacks.